XBIO — Xenetic Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $7.01m
- -$0.87m
- $2.98m
Annual cashflow statement for Xenetic Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.65 | -6.55 | -4.13 | -3.96 | -2.68 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.446 | 2.33 | 0.283 | 0.172 | 0.065 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.461 | -0.427 | -0.263 | 0.971 | 0.329 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -4.74 | -4.65 | -4.11 | -2.82 | -2.29 |
| Capital Expenditures | — | -0.5 | 0 | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | — | -0.5 | 0 | — | — |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 11.5 | 0 | — | — | 4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.72 | -5.15 | -4.11 | -2.82 | 1.72 |